
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
Business Of Biotech
00:00
Is It a Bacterial Consortium?
Asi, is this really like, uncharted territory? It's a good question. I remember it was probably round about, you know, christmas 20, fourth in alan. The big break through came pretty quickly. And that's how we developed the platform to think about rat car. We can start luk, thats systemic disease ad i thing that's the real important point. Think a lot of people think the market, by him, is just about diseases in the gut. But when you needs impact temune system, or you want to o modulate the good brainaxis, i think you got to be really clever and figure out the functionality,. That is drug like.
Transcript
Play full episode